共 130 条
[1]
Crean-Tate KK(2020)Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy Am J Obstet Gynecol 222 103-113
[2]
Faubion SS(2017)Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause Menopause 24 1246-1256
[3]
Pederson HJ(2020)Genitourinary syndrome of menopause Post Reprod Health 26 111-114
[4]
Vencill JA(2014)Vaginal estrogen for genitourinary syndrome of menopause Obstet Gynecol 124 1147-1156
[5]
Batur P(2018)Anticholinergic drugs and risk of dementia: case-control study BMJ 25 1084-1093
[6]
Labrie F(2019)Anticholinergic drug exposure and the risk of dementia: a nested case-control study JAMA Intern Med 179 28-37
[7]
Archer DF(2021)Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis Neurourol Urodyn 40 327-336
[8]
Martel C(2003)Prevalence and burden of overactive bladder in the United States World J Urol 20 8-13
[9]
Vaillancourt M(2016)The burden of overactive bladder on US public health Curr Bladder Dysfunct Rep 11 46-52
[10]
Montesino M(2005)Management of post-menopausal vaginal atrophy and atrophic vaginitis Maturitas 15 892-897